Growth factors are essential for long-term growth and proliferation of cell lines in serum-free media formulations. Recombinant insulin is used to supplement serum free cell culture, however its primary use is as a therapeutic for the treatment of diabetes. For cell culture users this can mean supply insecurity and disruption.
In contrast, LONG®R3IGF-I is a dedicated raw material manufactured exclusively for the industrial cell culture market providing a consistent, compliant and reliable alternative to recombinant insulin.
LONG®R3IGF-I